William Douglas Winkelman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pelvic Organ Prolapse | 6 | 2021 | 119 | 3.690 |
Why?
|
Gynecologic Surgical Procedures | 6 | 2021 | 331 | 2.270 |
Why?
|
Vagina | 4 | 2021 | 776 | 1.790 |
Why?
|
Suburethral Slings | 3 | 2021 | 70 | 1.750 |
Why?
|
Urinary Incontinence, Stress | 2 | 2021 | 172 | 1.490 |
Why?
|
Urinary Incontinence, Urge | 3 | 2018 | 37 | 1.450 |
Why?
|
Uterine Prolapse | 2 | 2021 | 74 | 1.050 |
Why?
|
Patient Satisfaction | 3 | 2021 | 3396 | 1.000 |
Why?
|
Surgical Mesh | 2 | 2019 | 249 | 0.760 |
Why?
|
Directive Counseling | 1 | 2020 | 173 | 0.730 |
Why?
|
Emotions | 2 | 2021 | 2441 | 0.720 |
Why?
|
Ambulatory Surgical Procedures | 2 | 2021 | 453 | 0.710 |
Why?
|
Fecal Incontinence | 1 | 2021 | 221 | 0.700 |
Why?
|
Salaries and Fringe Benefits | 1 | 2020 | 270 | 0.660 |
Why?
|
Reproductive Health Services | 1 | 2018 | 80 | 0.650 |
Why?
|
Calculi | 1 | 2016 | 44 | 0.580 |
Why?
|
Urology | 1 | 2020 | 371 | 0.580 |
Why?
|
Vaginal Diseases | 1 | 2016 | 96 | 0.550 |
Why?
|
Gynecology | 1 | 2020 | 474 | 0.540 |
Why?
|
Hysterectomy | 1 | 2021 | 904 | 0.530 |
Why?
|
Cryopreservation | 1 | 2018 | 630 | 0.510 |
Why?
|
Preimplantation Diagnosis | 1 | 2015 | 129 | 0.480 |
Why?
|
Catholicism | 1 | 2012 | 31 | 0.450 |
Why?
|
Urinary Incontinence | 1 | 2016 | 459 | 0.440 |
Why?
|
Perioperative Care | 1 | 2020 | 1070 | 0.440 |
Why?
|
Faculty, Medical | 1 | 2020 | 1162 | 0.430 |
Why?
|
Teratogens | 1 | 2012 | 114 | 0.430 |
Why?
|
Public Opinion | 1 | 2015 | 462 | 0.410 |
Why?
|
Contraceptive Agents | 1 | 2012 | 124 | 0.400 |
Why?
|
Pain, Postoperative | 1 | 2020 | 1624 | 0.380 |
Why?
|
Drugs, Investigational | 1 | 2012 | 233 | 0.360 |
Why?
|
Analgesics, Opioid | 2 | 2020 | 3367 | 0.330 |
Why?
|
Infertility, Female | 1 | 2013 | 756 | 0.320 |
Why?
|
Patient Readmission | 1 | 2021 | 2962 | 0.310 |
Why?
|
Spirituality | 1 | 2011 | 397 | 0.310 |
Why?
|
Fetus | 1 | 2013 | 1836 | 0.290 |
Why?
|
Informed Consent | 1 | 2012 | 958 | 0.280 |
Why?
|
Reoperation | 3 | 2021 | 4174 | 0.270 |
Why?
|
Postoperative Complications | 3 | 2021 | 15098 | 0.260 |
Why?
|
Female | 24 | 2021 | 377334 | 0.250 |
Why?
|
Recurrence | 3 | 2021 | 8269 | 0.240 |
Why?
|
Bone and Bones | 1 | 2013 | 2566 | 0.220 |
Why?
|
Genetic Testing | 1 | 2015 | 3319 | 0.220 |
Why?
|
Sacrum | 2 | 2021 | 304 | 0.220 |
Why?
|
Pessaries | 1 | 2021 | 18 | 0.220 |
Why?
|
Benzhydryl Compounds | 2 | 2018 | 705 | 0.220 |
Why?
|
Retrospective Studies | 8 | 2021 | 72255 | 0.210 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5010 | 0.210 |
Why?
|
Hysterectomy, Vaginal | 1 | 2020 | 35 | 0.210 |
Why?
|
Pelvic Floor | 1 | 2021 | 136 | 0.190 |
Why?
|
Middle Aged | 14 | 2021 | 214871 | 0.190 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 3950 | 0.190 |
Why?
|
Quality of Life | 3 | 2021 | 11691 | 0.190 |
Why?
|
Humans | 25 | 2021 | 715124 | 0.180 |
Why?
|
Aged | 12 | 2021 | 162674 | 0.180 |
Why?
|
Urologic Surgical Procedures | 1 | 2021 | 293 | 0.170 |
Why?
|
Anal Canal | 1 | 2021 | 344 | 0.170 |
Why?
|
Nocturia | 1 | 2018 | 23 | 0.170 |
Why?
|
Muscarinic Antagonists | 1 | 2018 | 131 | 0.160 |
Why?
|
Access to Information | 1 | 2020 | 304 | 0.160 |
Why?
|
Neoplasms | 2 | 2018 | 20515 | 0.150 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2020 | 398 | 0.150 |
Why?
|
Acetaminophen | 1 | 2020 | 549 | 0.150 |
Why?
|
Healthcare Disparities | 2 | 2021 | 3027 | 0.140 |
Why?
|
Clinical Trials as Topic | 1 | 2012 | 8016 | 0.140 |
Why?
|
Postoperative Period | 1 | 2020 | 1854 | 0.140 |
Why?
|
Marital Status | 1 | 2017 | 440 | 0.140 |
Why?
|
Cohort Studies | 4 | 2021 | 39804 | 0.130 |
Why?
|
Cross-Sectional Studies | 4 | 2020 | 23283 | 0.130 |
Why?
|
Treatment Outcome | 5 | 2021 | 62186 | 0.130 |
Why?
|
Parity | 1 | 2017 | 893 | 0.120 |
Why?
|
Schools, Medical | 1 | 2020 | 882 | 0.120 |
Why?
|
Hysteroscopy | 1 | 2013 | 89 | 0.120 |
Why?
|
Patient Preference | 1 | 2019 | 858 | 0.110 |
Why?
|
Age Factors | 2 | 2021 | 18789 | 0.110 |
Why?
|
Venous Thrombosis | 1 | 2021 | 1240 | 0.110 |
Why?
|
Incidental Findings | 1 | 2016 | 667 | 0.100 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2266 | 0.100 |
Why?
|
Pain Measurement | 1 | 2020 | 3509 | 0.100 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6538 | 0.090 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2009 | 144 | 0.090 |
Why?
|
Abortion, Induced | 1 | 2013 | 372 | 0.090 |
Why?
|
Time Factors | 2 | 2021 | 41081 | 0.090 |
Why?
|
Reconstructive Surgical Procedures | 1 | 2021 | 2126 | 0.080 |
Why?
|
Pulmonary Embolism | 1 | 2021 | 2395 | 0.080 |
Why?
|
Adult | 8 | 2021 | 212129 | 0.080 |
Why?
|
Pregnancy | 3 | 2015 | 27180 | 0.080 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39285 | 0.080 |
Why?
|
Young Adult | 4 | 2021 | 56155 | 0.080 |
Why?
|
Attitude of Health Personnel | 1 | 2020 | 3894 | 0.070 |
Why?
|
Double-Blind Method | 2 | 2018 | 11900 | 0.070 |
Why?
|
Adolescent | 4 | 2021 | 84999 | 0.070 |
Why?
|
Pain | 1 | 2021 | 4662 | 0.070 |
Why?
|
Databases, Factual | 1 | 2021 | 7836 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2018 | 3463 | 0.070 |
Why?
|
Aged, 80 and over | 2 | 2021 | 58505 | 0.070 |
Why?
|
Receptors, CXCR4 | 1 | 2009 | 735 | 0.060 |
Why?
|
Health Care Surveys | 1 | 2011 | 2509 | 0.060 |
Why?
|
Male | 6 | 2020 | 351081 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7480 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2020 | 21790 | 0.060 |
Why?
|
Sleep | 1 | 2018 | 4210 | 0.060 |
Why?
|
Chronic Disease | 1 | 2016 | 9022 | 0.050 |
Why?
|
Ultrasonography | 1 | 2013 | 5943 | 0.050 |
Why?
|
Laparotomy | 1 | 2021 | 473 | 0.040 |
Why?
|
Fibroblasts | 1 | 2009 | 4283 | 0.040 |
Why?
|
Boston | 1 | 2011 | 9400 | 0.040 |
Why?
|
Prognosis | 1 | 2018 | 29168 | 0.040 |
Why?
|
Urinary Bladder, Overactive | 1 | 2018 | 101 | 0.040 |
Why?
|
Prospective Studies | 1 | 2021 | 51181 | 0.040 |
Why?
|
Asian Americans | 1 | 2021 | 678 | 0.040 |
Why?
|
Urinary Tract Infections | 1 | 2021 | 780 | 0.030 |
Why?
|
Blood Transfusion | 1 | 2021 | 1258 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2011 | 16011 | 0.030 |
Why?
|
Laparoscopy | 1 | 2021 | 1990 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2009 | 411 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9968 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2021 | 12477 | 0.020 |
Why?
|
Self Report | 1 | 2018 | 3420 | 0.020 |
Why?
|
Interleukin-8 | 1 | 2009 | 698 | 0.020 |
Why?
|
Collagen Type I | 1 | 2009 | 577 | 0.020 |
Why?
|
African Americans | 1 | 2021 | 5065 | 0.020 |
Why?
|
Logistic Models | 1 | 2021 | 13594 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2009 | 20059 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2009 | 1751 | 0.010 |
Why?
|
Breast | 1 | 2009 | 1820 | 0.010 |
Why?
|
Cell Movement | 1 | 2009 | 5468 | 0.010 |
Why?
|
Gene Expression | 1 | 2009 | 8010 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2009 | 13292 | 0.010 |
Why?
|
United States | 1 | 2021 | 67665 | 0.010 |
Why?
|
Signal Transduction | 1 | 2009 | 23973 | 0.000 |
Why?
|
Mice | 1 | 2009 | 80995 | 0.000 |
Why?
|
Animals | 1 | 2009 | 170726 | 0.000 |
Why?
|